# MFSD12

## Overview
MFSD12, or major facilitator superfamily domain containing 12, is a gene that encodes a transmembrane protein belonging to the major facilitator superfamily (MFS). This protein is primarily involved in the transport of small solutes across cellular membranes, particularly within melanosomes and lysosomes. The MFSD12 protein plays a significant role in the regulation of skin pigmentation by influencing the balance between eumelanin and pheomelanin production, and it is also implicated in maintaining lysosomal cysteine homeostasis, which is crucial for preventing ferroptosis, a form of cell death. Variations in the expression of MFSD12 are associated with differences in skin pigmentation among human populations and have been linked to various diseases, including cancer, where it is involved in pathways that regulate cell proliferation and survival (Crawford2017Loci; Wei2018Bioinformaticsbased; Ding2024The).

## Structure
MFSD12 is a transmembrane protein that is part of the major facilitator superfamily (MFS), which typically consists of proteins with 12 transmembrane segments (TMS) forming a helical bundle (Perland2017Characteristics). The protein is encoded by the MFSD12 gene located on chromosome 19 and is predominantly found in melanosomes and lysosomes (Ding2024The). 

The primary structure of MFSD12 includes a sequence that is evolutionarily conserved among various species, indicating its functional importance (Perland2017Characteristics). Although specific details about the secondary and tertiary structures of MFSD12 are not provided, the general characteristics of MFS proteins suggest a typical arrangement of 12 TMS, which is crucial for their role in solute transport (Perland2017Characteristics).

Post-translational modifications of MFSD12 may include phosphorylation, which can affect its function and localization, although specific modifications for MFSD12 are not detailed in the available context. Alternative splicing of the MFSD12 gene may result in different isoforms, potentially influencing its functional diversity. The protein's involvement in transporting cysteine into melanosomes and lysosomes is critical for skin pigmentation and disease progression (Ding2024The).

## Function
The MFSD12 gene encodes a transmembrane protein that is part of the major facilitator superfamily, which is involved in the transport of small solutes across cell membranes. In healthy human cells, MFSD12 is predominantly localized to melanosomes and lysosomes, where it plays a crucial role in the transport of cysteine, a semi-essential amino acid. This transport is essential for the synthesis of intracellular metabolites like glutathione, a powerful antioxidant, and for maintaining lysosomal cysteine homeostasis, which is important for preventing ferroptosis, a type of cell death mediated by iron and peroxidation (Ding2024The).

MFSD12 is highly expressed in primary human melanocytes, the cells responsible for pigment production in the skin. It influences skin pigmentation by regulating the synthesis of melanin, particularly affecting the balance between eumelanin and pheomelanin production. The gene's expression is associated with pigmentation differences, with decreased expression linked to deeper pigmentation (Crawford2017Loci; Marks2021How). MFSD12's role in pigmentation is consistent with its lower expression levels in melanocytes from individuals with African ancestry, correlating with higher eumelanin content (Crawford2017Loci).

## Clinical Significance
Mutations and alterations in the expression of the MFSD12 gene have been linked to several diseases and conditions, particularly in the context of cancer and pigmentation disorders. In cancer, MFSD12 is notably implicated in melanoma, breast cancer, and lung cancer. Overexpression of MFSD12 in melanoma is associated with increased cell proliferation and poor prognosis, as it promotes the G1-to-S phase transition in the cell cycle and activates the PI3K-AKT signaling pathway. This makes MFSD12 a potential prognostic biomarker and therapeutic target in melanoma (Wei2018Bioinformaticsbased). In breast cancer, MFSD12 overexpression is linked to unfavorable treatment outcomes due to its role in maintaining lysosomal cysteine levels, which are crucial for cellular redox homeostasis (Ding2024The). In lung cancer, MFSD12 expression is associated with tumor-associated macrophages, where its upregulation correlates with worse survival outcomes (Ding2024The).

In terms of pigmentation, MFSD12 is involved in the regulation of melanin production. Variants in MFSD12 have been associated with skin pigmentation differences across populations. For instance, certain alleles linked to dark pigmentation are prevalent in African populations, while others associated with lighter pigmentation are common in Europeans and East Asians (Crawford2017Loci; Feng2021Evolutionary). In dogs, a missense variant in MFSD12 is associated with the dilution of phaeomelanin, leading to white or cream coat colors (Hédan2019Identification). These findings underscore the gene's role in pigmentation across species.

## Interactions
MFSD12, a member of the major facilitator superfamily, is involved in various cellular processes, including pigmentation and lysosomal function. It is primarily located in lysosomes and melanosomes, where it plays a role in cysteine transport. The protein interacts with other proteins within these cellular compartments, influencing its function and localization. 

In the context of cancer, MFSD12 is implicated in the PI3K-AKT signaling pathway, which is crucial for cell proliferation and survival. This interaction is particularly significant in melanoma, where MFSD12 upregulation promotes cell proliferation and tumor progression through this pathway (Wei2018Bioinformaticsbased). In non-small cell lung cancer (NSCLC), MFSD12 is targeted by miR-4732-3p, a microRNA that downregulates its expression, thereby affecting the AKT/p21 signaling pathway. This interaction leads to cell cycle arrest and reduced cell proliferation, highlighting MFSD12's role in cancer progression (Zhuang2024Tumorsuppressive).

MFSD12 is also part of the solute carrier (SLC) superfamily interactome, where it is identified as a lysosomal bait. This suggests its involvement in interactions with other lysosomal proteins, although specific protein partners are not detailed (Frommelt2024The). These interactions underline MFSD12's role in cellular transport and its potential impact on various biological processes.


## References


[1. (Zhuang2024Tumorsuppressive) Wanzhen Zhuang, Chengxiu Liu, Yilin Hong, Yue Zheng, Minjian Huang, Haijun Tang, Lilan Zhao, Zhixin Huang, Mingshu Tu, Lili Yu, Jianlin Chen, Yi Zhang, Xiongfeng Chen, Fan Lin, Qi Gao, Chundong Yu, and Yi Huang. Tumor-suppressive mir-4732-3p is sorted into fucosylated exosome by hnrnpk to avoid the inhibition of lung cancer progression. Journal of Experimental &amp; Clinical Cancer Research, April 2024. URL: http://dx.doi.org/10.1186/s13046-024-03048-1, doi:10.1186/s13046-024-03048-1. This article has 1 citations.](https://doi.org/10.1186/s13046-024-03048-1)

[2. (Wei2018Bioinformaticsbased) Chuan-Yuan Wei, Meng-Xuan Zhu, Nan-Hang Lu, Rui Peng, Xuan Yang, Peng-Fei Zhang, Lu Wang, and Jian-Ying Gu. Bioinformatics-based analysis reveals elevated mfsd12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma. Oncogene, 38(11):1876–1891, November 2018. URL: http://dx.doi.org/10.1038/s41388-018-0531-6, doi:10.1038/s41388-018-0531-6. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-018-0531-6)

[3. (Perland2017Characteristics) Emelie Perland, Sonchita Bagchi, Axel Klaesson, and Robert Fredriksson. Characteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression. Open Biology, 7(9):170142, September 2017. URL: http://dx.doi.org/10.1098/rsob.170142, doi:10.1098/rsob.170142. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1098/rsob.170142)

[4. (Marks2021How) Michael S. Marks and William J. Pavan. How a membrane transporter keeps melanocytes in the red. Pigment Cell &amp; Melanoma Research, 34(4):666–669, May 2021. URL: http://dx.doi.org/10.1111/pcmr.12973, doi:10.1111/pcmr.12973. This article has 1 citations.](https://doi.org/10.1111/pcmr.12973)

[5. (Crawford2017Loci) Nicholas G. Crawford, Derek E. Kelly, Matthew E. B. Hansen, Marcia H. Beltrame, Shaohua Fan, Shanna L. Bowman, Ethan Jewett, Alessia Ranciaro, Simon Thompson, Yancy Lo, Susanne P. Pfeifer, Jeffrey D. Jensen, Michael C. Campbell, William Beggs, Farhad Hormozdiari, Sununguko Wata Mpoloka, Gaonyadiwe George Mokone, Thomas Nyambo, Dawit Wolde Meskel, Gurja Belay, Jake Haut, Harriet Rothschild, Leonard Zon, Yi Zhou, Michael A. Kovacs, Mai Xu, Tongwu Zhang, Kevin Bishop, Jason Sinclair, Cecilia Rivas, Eugene Elliot, Jiyeon Choi, Shengchao A. Li, Belynda Hicks, Shawn Burgess, Christian Abnet, Dawn E. Watkins-Chow, Elena Oceana, Yun S. Song, Eleazar Eskin, Kevin M. Brown, Michael S. Marks, Stacie K. Loftus, William J. Pavan, Meredith Yeager, Stephen Chanock, and Sarah A. Tishkoff. Loci associated with skin pigmentation identified in african populations. Science, November 2017. URL: http://dx.doi.org/10.1126/science.aan8433, doi:10.1126/science.aan8433. This article has 254 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aan8433)

[6. (Feng2021Evolutionary) Yuanqing Feng, Michael A McQuillan, and Sarah A Tishkoff. Evolutionary genetics of skin pigmentation in african populations. Human Molecular Genetics, 30(R1):R88–R97, January 2021. URL: http://dx.doi.org/10.1093/hmg/ddab007, doi:10.1093/hmg/ddab007. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddab007)

7. (Frommelt2024The) The solute carrier superfamily interactome. This article has 0 citations.

[8. (Ding2024The) Liqiong Ding. The emerging role and clinicopathological significance of mfsd12 in cancer and lysosomal storage diseases. Frontiers in Pharmacology, June 2024. URL: http://dx.doi.org/10.3389/fphar.2024.1398320, doi:10.3389/fphar.2024.1398320. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2024.1398320)

[9. (Hédan2019Identification) Benoit Hédan, Edouard Cadieu, Nadine Botherel, Caroline Dufaure de Citres, Anna Letko, Maud Rimbault, Cord Drögemüller, Vidhya Jagannathan, Thomas Derrien, Sheila Schmutz, Tosso Leeb, and Catherine André. Identification of a missense variant in mfsd12 involved in dilution of phaeomelanin leading to white or cream coat color in dogs. Genes, 10(5):386, May 2019. URL: http://dx.doi.org/10.3390/genes10050386, doi:10.3390/genes10050386. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes10050386)